Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Bilastine 20 mg Tablets (Generic vs Bilaxten) in Healthy Thai Volunteers Under Fasting
TCTR20250226007Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bilastine in allergic rhinitis (AR) and chronic urticaria (CU) (2 arms), sponsored by International Bio Service. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
bilastine
03
Conditions
allergic rhinitis (AR)chronic urticaria (CU)
Beyond the preview
Go deeper on TCTR20250226007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250226007.